Some experts believe race-day meds are a drag on U.S. horse racing

06/13/2011 | New York Times (tiered subscription model), The

The U.S. thoroughbred horse racing industry is experiencing a malaise, with betting amounts, purses and the number of races run all having slipped downward between 2007 and 2010. Some participants in the recent International Summit on Race Day Medication in New York attributed this decline in the public's interest in horse racing in large measure to the use of performance-enhancing drugs in racehorses.

View Full Article in:

New York Times (tiered subscription model), The

Published in Brief:

SmartBrief Job Listings for Health Care

Job Title Company Location
Senior Director, Research
America's Health Insurance Plans (AHIP)
Washington, DC
Stop Loss Sales Executive
Blue Cross Blue Shield of MA
Boston, MA
Regional Director, Southeastern Region - State Affairs
America's Health Insurance Plans (AHIP)
Washington, DC
Field Representative-Oklahoma and Kansas
National Rural Electric Cooperative Association (NRECA)
Multiple Locations, SL_Multiple Locations
Market Intelligence Manager
Olympus Corporation of the Americas
Southborough, MA